Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001130319-07-000530
Filing Date
2007-07-30
Accepted
2007-07-30 16:07:34
Documents
3
Period of Report
2007-07-27

Document Format Files

Seq Description Document Type Size
1 FORM 6-K o37171e6vk.htm 6-K 258191
2 GRAPHIC o37171o3717100.gif GRAPHIC 11630
3 GRAPHIC o37171o3717101.gif GRAPHIC 2154
  Complete submission text file 0001130319-07-000530.txt   278907
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 071009634
SIC: 2834 Pharmaceutical Preparations